(Q35036590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

ubiquitin-proteasome system

16 December 2019

main subject

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Maria Masucci

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Nico P Dantuma

series ordinal

1

1 reference

5 August 2017

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Cancer Biology

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

69-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Epstein-Barr virus: adaptation to a life within the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Viral strategies of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

1 reference

7 January 2021

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Structure and function of the WW domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

LMP1 structure and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Endoplasmic reticulum-associated protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Role of LMP1 in immune control of EBV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Deubiquitinating enzymes: their diversity and emerging roles

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

A giant protease with potential to substitute for some functions of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

A proteolytic system that compensates for loss of proteasome function

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2802%2900101-3

7 January 2021

10.1016/S1044-579X(02)00101-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12507558%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference